Barclays Maintains Overweight on Exscientia, Lowers Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Peter Lawson maintains an Overweight rating on Exscientia (NASDAQ:EXAI) but lowers the price target from $10 to $9.
July 29, 2024 | 3:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Peter Lawson maintains an Overweight rating on Exscientia but lowers the price target from $10 to $9.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100